×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Rain Oncology Inc. (RAIN) NASDAQ

$1.21 - (-)

Market Cap: -

As of 01/25/24 12:00 AM EST. Market closed.

Rain Oncology Inc. (RAIN)
NASDAQ

$1.21
- (-)

Market Cap: -

As of 01/25/24 12:00 AM EST. Market closed.

Add to Portfolio

rain therapeutics is a san francisco bay area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic ... read more

rain therapeutics is a san francisco bay area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
38
Address
.
PRICE CHART FOR RAIN ONCOLOGY INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$1.21
Days Range
$1.21 - $1.27
52 week range
- - -
Volume
3,706,028
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
27,579,947
Open
-
Previous Close
$1.21
Days Range
$1.21 - $1.27
52 week range
- - -
Volume
3,706,028
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
27,579,947
FINANCIAL STATEMENTS FOR RAIN ONCOLOGY INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR RAIN ONCOLOGY INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
TANG KEVIN C10% OwnerDec 18, 2023 Sale$1.2140,13248,5603,850,513Dec 18, 2023, 06:29 PM
TANG KEVIN C10% OwnerDec 15, 2023 Sale$1.20109,435131,3223,890,645Dec 18, 2023, 06:29 PM
TANG KEVIN C10% OwnerDec 14, 2023 Sale$1.2124,40629,5314,000,080Dec 18, 2023, 06:29 PM
TANG KEVIN C10% OwnerOct 11, 2023 Buy$0.9774,81272,5683,815,153Oct 13, 2023, 04:57 PM
TANG KEVIN C10% OwnerOct 13, 2023 Buy$0.99131,631130,3154,024,486Oct 13, 2023, 04:57 PM
TANG KEVIN C10% OwnerOct 12, 2023 Buy$0.9877,70276,1483,892,855Oct 13, 2023, 04:57 PM
TANG KEVIN C10% OwnerJun 01, 2023 Buy$1.11333,325370,5343,740,341Jun 01, 2023, 06:46 PM
TANG KEVIN C10% OwnerMay 31, 2023 Buy$1.08166,180179,5743,407,016Jun 01, 2023, 06:46 PM
TANG KEVIN C10% OwnerMay 30, 2023 Buy$1.03588,768608,6553,240,836Jun 01, 2023, 06:46 PM
Boxer Capital, LLCSee remarks.May 22, 2023 Sale$1.25995,0001,243,7501,152,212May 24, 2023, 08:05 PM
BERGER FRANKLIN MDirectorNov 21, 2022 Buy$7.8045,000351,000928,207Nov 23, 2022, 05:45 PM
BERGER FRANKLIN MDirectorNov 22, 2022 Buy$8.2777,000636,7901,005,207Nov 23, 2022, 05:45 PM
BERGER FRANKLIN MDirectorNov 08, 2022 Buy$5.8342,881249,996883,207Nov 14, 2022, 04:17 PM
BVF PARTNERS L P/ILDirectorNov 08, 2022 Buy$5.831,710,3589,971,3872,870,985Nov 10, 2022, 06:31 PM
Davis Aaron I.DirectorNov 04, 2022 Buy$5.83972,2125,667,9962,147,212Nov 08, 2022, 04:30 PM
Doebele RobertSee RemarksJul 06, 2022 Option Exercise$3.953,89015,366476,827Jul 07, 2022, 06:02 PM
Vellanki AvanishChairman and CEOJun 01, 2022 Buy$2.2925,00057,2502,471,627Jun 02, 2022, 04:05 PM
Doebele RobertSee RemarksApr 13, 2022 Option Exercise$3.953,00011,850472,937Apr 15, 2022, 04:30 PM
Doebele RobertSee RemarksMar 31, 2022 Option Exercise$3.952,0007,900469,937Apr 04, 2022, 04:15 PM
Vellanki AvanishPresident and CEOMar 11, 2022 Option Exercise$4.0014,46857,8722,837,009Mar 15, 2022, 03:23 PM
BVF PARTNERS L P/ILDirectorJan 06, 2022 Buy$12.0061,343736,0181,141,759Jan 10, 2022, 06:03 PM
BVF PARTNERS L P/ILDirectorJan 07, 2022 Buy$12.00496,3855,956,6201,734,960Jan 10, 2022, 06:03 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 08, 2021 Sale$13.157,50098,6212,518,613Oct 13, 2021, 05:47 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 07, 2021 Sale$14.8113,368197,9182,523,937Oct 13, 2021, 05:47 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 12, 2021 Sale$13.407,30697,9002,487,019Oct 13, 2021, 05:47 PM
PERCEPTIVE ADVISORS LLC10% OwnerOct 11, 2021 Sale$12.5121,826273,0402,503,676Oct 13, 2021, 05:47 PM
BVF PARTNERS L P/ILDirectorSep 21, 2021 Buy$13.9411,033153,8291,479,460Sep 23, 2021, 08:05 PM
BERGER FRANKLIN MDirectorSep 21, 2021 Buy$14.303,78654,140840,326Sep 23, 2021, 05:21 PM
BVF PARTNERS L P/ILDirectorSep 13, 2021 Buy$16.49392,2696,468,5161,473,119Sep 15, 2021, 05:23 PM
BVF PARTNERS L P/ILDirectorJul 06, 2021 Buy$15.25269,7234,113,2761,259,873Jul 06, 2021, 07:34 PM
BVF PARTNERS L P/ILDirectorJul 01, 2021 Buy$15.65317,2794,965,4161,113,757Jul 06, 2021, 07:34 PM
BVF PARTNERS L P/ILDirectorMay 24, 2021 Buy$15.901,36121,633941,300May 25, 2021, 08:31 PM
BVF PARTNERS L P/ILDirectorMay 21, 2021 Buy$15.94121,9861,944,701940,581May 25, 2021, 08:31 PM
BVF PARTNERS L P/ILDirectorMay 19, 2021 Buy$15.8817,268274,290874,339May 20, 2021, 07:18 PM
BVF PARTNERS L P/ILDirectorMay 18, 2021 Buy$16.65191,1973,183,430865,148May 20, 2021, 07:18 PM
Cormorant Asset Management, LPFormer 10% OwnerApr 27, 2021 Buy$17.00450,0007,650,0002,776,657Apr 29, 2021, 04:02 PM
BVF PARTNERS L P/ILDirectorApr 23, 2021 Option Exercise$16.901,105,89618,694,901714,942Apr 27, 2021, 08:41 PM
BVF PARTNERS L P/ILDirectorApr 26, 2021 Option Exercise$14.9027,413408,478729,732Apr 27, 2021, 08:41 PM
PERCEPTIVE ADVISORS LLC10% OwnerApr 27, 2021 Buy$17.00550,0009,350,0002,537,019Apr 27, 2021, 07:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
TANG KEVIN C10% Owner12/18/202348,560
TANG KEVIN C10% Owner12/15/2023131,322
TANG KEVIN C10% Owner12/14/202329,531
TANG KEVIN C10% Owner10/11/202372,568
TANG KEVIN C10% Owner10/13/2023130,315
TANG KEVIN C10% Owner10/12/202376,148
TANG KEVIN C10% Owner06/01/2023370,534
TANG KEVIN C10% Owner05/31/2023179,574
TANG KEVIN C10% Owner05/30/2023608,655
Boxer Capital, LLCSee remarks.05/22/20231,243,750
BERGER FRANKLIN MDirector11/21/2022351,000
BERGER FRANKLIN MDirector11/22/2022636,790
BERGER FRANKLIN MDirector11/08/2022249,996
BVF PARTNERS L P/ILDirector11/08/20229,971,387
Davis Aaron I.Director11/04/20225,667,996
Doebele RobertSee Remarks07/06/202215,366
Vellanki AvanishChairman and CEO06/01/202257,250
Doebele RobertSee Remarks04/13/202211,850
Doebele RobertSee Remarks03/31/20227,900
Vellanki AvanishPresident and CEO03/11/202257,872
BVF PARTNERS L P/ILDirector01/06/2022736,018
BVF PARTNERS L P/ILDirector01/07/20225,956,620
PERCEPTIVE ADVISORS LLC10% Owner10/08/202198,621
PERCEPTIVE ADVISORS LLC10% Owner10/07/2021197,918
PERCEPTIVE ADVISORS LLC10% Owner10/12/202197,900
PERCEPTIVE ADVISORS LLC10% Owner10/11/2021273,040
BVF PARTNERS L P/ILDirector09/21/2021153,829
BERGER FRANKLIN MDirector09/21/202154,140
BVF PARTNERS L P/ILDirector09/13/20216,468,516
BVF PARTNERS L P/ILDirector07/06/20214,113,276
BVF PARTNERS L P/ILDirector07/01/20214,965,416
BVF PARTNERS L P/ILDirector05/24/202121,633
BVF PARTNERS L P/ILDirector05/21/20211,944,701
BVF PARTNERS L P/ILDirector05/19/2021274,290
BVF PARTNERS L P/ILDirector05/18/20213,183,430
Cormorant Asset Management, LPFormer 10% Owner04/27/20217,650,000
BVF PARTNERS L P/ILDirector04/23/202118,694,901
BVF PARTNERS L P/ILDirector04/26/2021408,478
PERCEPTIVE ADVISORS LLC10% Owner04/27/20219,350,000
Load More Insider Transactions
FUNDS WITH A POSITION IN RAIN ONCOLOGY INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.1,090,7070.00003%7.42%Other
GEODE CAPITAL MANAGEMENT, LLC331,0590.00004%0.56%Other
RENAISSANCE TECHNOLOGIES LLC11,1000.00002%NewOther
CHANGE IN SHARES OUTSTANDING FOR RAIN ONCOLOGY INC
STOCK BUYBACKS FOR RAIN ONCOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.03%
1Q
09/30/2023
03/31/2023
0.10%
2Q
09/30/2023
12/31/2022
12.50%
3Q
09/30/2023
09/30/2022
36.93%
4Q
09/30/2023
06/30/2022
37.11%
5Q
09/30/2023
03/31/2022
37.21%
6Q
09/30/2023
12/31/2021
87.45%
7Q
09/30/2023
09/30/2021
37.44%
8Q
09/30/2023
06/30/2021
74.67%
9Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.03%
1Q
03/31/2023
0.10%
2Q
12/31/2022
12.50%
3Q
09/30/2022
36.93%
4Q
06/30/2022
37.11%
5Q
03/31/2022
37.21%
6Q
12/31/2021
87.45%
7Q
09/30/2021
37.44%
8Q
06/30/2021
74.67%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR RAIN ONCOLOGY INC
LOADING...